Debu Tripathy, MD, discusses the evolving treatment landscape of HER2-positive breast cancer.
Debu Tripathy, MD, The University of Texas MD Anderson Cancer Center
Advertisement
Articles by Debu Tripathy, MD, The University of Texas MD Anderson Cancer Center
Advertisement
Latest Updated Articles
Dr. Tripathy on the Evolving Treatment Landscape of HER2+ Breast CancerPublished: September 2nd 2020 | Updated:
Advertisement
Advertisement
Trending on OncLive
1
Ultra-Sensitive ctDNA and CSF Liquid Biopsy May Refine Monitoring and Adaptive Trial Designs in Metastatic Breast Cancer
2
Lurbinectedin-Based Triplet Shows Clinical Benefit in Advanced Soft Tissue Sarcoma
3
FDA Grants Fast Track Designation to IBI3003 in Relapsed/Refractory Multiple Myeloma
4
FDA Accepts BLA for Ivonescimab Plus Chemotherapy in EGFR-Mutant NSCLC After TKI Progression
5